This example dataset shows the findings associated with a Cardiac Magnetic Resonance Imaging procedure related to ejection fraction. CVDTC is the date of the CMR procedure, CVDY is the study. For the purposes of this example, the participant was enrolled in the study on 20-May-2021 and the study visits were every two months. The CVLNKID variable is used to identify a record to show a relationship between records in separate domains.
| Dataset wrap |
|---|
|
| Rowcaps |
|---|
| Rows 1-8: | Show the baseline CMR ejection fraction measurements for participant DMD-EF-01-101 at VISIT 1. | | Rows 9-16: | Show the CMR ejection fraction measurements for participant DMD-EF-01-101 at VISIT 6. |
|
| Dataset2 |
|---|
| | Row | STUDYID | DOMAIN | USUBJID | CVSEQ | CVLNKID | CVTESTCD | CVTEST | CVORRES | CVORRESU | CVSTRESC | CVSTRESN | CVSTRESU | CVLOC | CVMETHOD | VISITNUM | VISIT | CVDTC | CVDY |
|---|
| 1 | DMD-EF | CV | DMD-EF-01-101 | 1 |
| ESV | End Systolic Volume | 32 | mL | 32 | 32 | mL | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 2 | DMD-EF | CV | DMD-EF-01-101 | 2 |
| EDV | End Diastolic Volume | 95 | mL | 95 | 95 | mL | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 3 | DMD-EF | CV | DMD-EF-01-101 | 3 | 2 | LVEF_C | Left Ventricular Ejection Fraction, Calculated | 67 | % | 67 | 67 | % | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 4 | DMD-EF | CV | DMD-EF-01-101 | 4 | 2 | CARDOUT | Cardiac Output | 5.4 | L/min | 5.4 | 5.4 | L/min | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 5 | DMD-EF | CV | DMD-EF-01-101 | 5 |
| ESV | End Systolic Volume | 24 | mL | 24 | 24 | mL | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 6 | DMD-EF | CV | DMD-EF-01-101 | 6 |
| EDV | End Diastolic Volume | 90 | mL | 90 | 90 | mL | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 7 | DMD-EF | CV | DMD-EF-01-101 | 7 | 2 | RVEF_C | Right Ventricular Ejection Fraction, Calculated | 74 | % | 74 | 74 | % | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 8 | DMD-EF | CV | DMD-EF-01-101 | 8 | 2 | CARDOUT | Cardiac Output | 5.6 | L/min | 5.6 | 5.6 | L/min | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 1 | VISIT 1 | 2022-05-16 | 1 | | 9 | DMD-EF | CV | DMD-EF-01-101 | 9 |
| ESV | End Systolic Volume | 37 | mL | 37 | 37 | mL | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 10 | DMD-EF | CV | DMD-EF-01-101 | 10 |
| EDV | End Diastolic Volume | 94 | mL | 94 | 94 | mL | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 11 | DMD-EF | CV | DMD-EF-01-101 | 11 | 2 | LVEF_C | Left Ventricular Ejection Fraction, Calculated | 60 | % | 60 | 60 | % | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 12 | DMD-EF | CV | DMD-EF-01-101 | 12 | 2 | CARDOUT | Cardiac Output | 4.0 | L/min | 4.0 | 4.0 | L/min | HEART, LEFT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 13 | DMD-EF | CV | DMD-EF-01-101 | 13 |
| ESV | End Systolic Volume | 36 | mL | 36 | 36 | mL | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 14 | DMD-EF | CV | DMD-EF-01-101 | 14 |
| EDV | End Diastolic Volume | 93 | mL | 93 | 93 | mL | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 15 | DMD-EF | CV | DMD-EF-01-101 | 15 | 2 | RVEF_C | Right Ventricular Ejection Fraction, Calculated | 61 | % | 61 | 61 | % | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 | | 16 | DMD-EF | CV | DMD-EF-01-101 | 16 | 2 | CARDOUT | Cardiac Output | 4.0 | L/min | 4.0 | 4.0 | L/min | HEART, RIGHT VENTRICLE | CARDIAC MAGNETIC RESONANCE IMAGING | 6 | VISIT 6 | 2023-06-01 | 355 |
|
|
The laboratory test, N-Terminal ProB-type Natriuretic Peptide, is a biomarker used in heart failure and is used with ejection fraction for diagnosis and treatment (https://pubmed.ncbi.nlm.nih.gov/34918487/; https://pubmed.ncbi.nlm.nih.gov/33039447/).
| Dataset wrap |
|---|
|
| Rowcaps |
|---|
| Row 1: | Shows the results for the N-Terminal ProB-type Natriuretic Peptide test for participant DMD-EF-01-101 at VISIT 1. | | Row 2: | Shows the results for the N-Terminal ProB-type Natriuretic Peptide test at Visit 6. |
|
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | USUBJID | LBSEQ | LBLNKID | LBTESTCD | LBTEST | LBCAT | LBORRES | LBORRESU | LBORNRLO | LBORNRHI | LBSTRESC | LBSTRESN | LBSTRESU | LBSTNRLO | LBSTRNHI | LBNRIND | LBLOINC | LBSPEC | VISITNUM | VISIT | LBDTC | LBDY | | 1 | DMD-EF | LB | DMD-EF-01-101 | 1 | 2 | BNPPRONT | N-Terminal ProB-type Natriuretic Peptide | CHEMISTRY | 40 | pg/mL | 0 | 100 | 40 | 40 | IU/L | 100 | 40 | NORMAL | 71425-3 | BLOOD | 1 | VISIT 1 | 2022-05-16 | 1 | | 2 | DMD-EF | LB | DMD-EF-01-101 | 2 | 2 | BNPPRONT | N-Terminal ProB-type Natriuretic Peptide | CHEMISTRY | 900 | pg/mL | 0 | 100 | 900 | 900 | IU/L | 100 | 900 | HIGH | 71425-3 | BLOOD | 6 | VISIT 6 | 2023-06-01 | 355 |
|
|
The relationship between CV and LB is represented in the Related Records dataset (RELREC). For more information on relating records, see the SDTMIG v3.4, Section 8.2.
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
Row | STUDYID | RDOMAIN | USUBJID | IDVAR | IDVARVAL | RELTYPE | RELID |
|---|
| 1 | DMD-EF | CV |
| CVLNKID |
| MANY | 2 | | 2 | DMD-EF | LB |
| LBLNKID |
| ONE | 2 |
|
|